GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · Real-Time Price · USD
2.370
+0.130 (5.80%)
At close: Apr 1, 2025, 4:00 PM
2.140
-0.230 (-9.70%)
After-hours: Apr 1, 2025, 4:00 PM EDT
GT Biopharma Market Cap
GT Biopharma has a market cap or net worth of $5.30 million as of April 1, 2025. Its market cap has decreased by -16.07% in one year.
Market Cap
5.30M
Enterprise Value
922.07K
1-Year Change
-16.07%
Ranking
Category
Stock Price
$2.37
Market Cap Chart
Since October 18, 1983, GT Biopharma's market cap has decreased from $937.50M to $5.30M, a decrease of -99.44%. That is a compound annual growth rate of -11.73%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.92B |
| UnitedHealth Group | 480.61B |
| Johnson & Johnson | 400.61B |
| AbbVie | 371.41B |
| Novo Nordisk | 305.46B |
| Abbott Laboratories | 230.24B |
| Merck & Co. | 226.96B |
| AstraZeneca | 225.46B |